About

About Advanced BioMatrix Advanced BioMatrix develops biologically relevant extracellular matrix (ECM) solutions that enable more predictive in vitro cancer models. Our portfolio includes native collagens (Types I–IV), fibronectin, hyaluronic acid, laminins, and photo-crosslinkable hydrogels designed to replicate key features of the tumor microenvironment. These materials support 2D, 3D, and bioprinted cancer systems for studying invasion, angiogenesis, immuno-oncology, and drug response. By providing highly characterized, pure and consistent ECM materials with tunable mechanical properties, Advanced BioMatrix helps researchers recreate key aspects of the in vivo tumor microenvironment and build physiologically meaningful cancer models that bridge the gap between conventional cell culture and in vivo biology.